Dubois, Pierre
(2025)
Pharmaceutical Regulation and Incentives for Innovation in an International Perspective.
TSE Working Paper, n. 25-1674, Toulouse
Preview |
Text
Download (1MB) | Preview |
Abstract
We examine pharmaceutical regulations and incentives for innovation from an international perspective, highlighting the public good nature of healthcare innovation and its cross-border diffusion. We summarize the empirical evidence on how push and pull incentives shape R&D investment, innovation, and global access. We emphasize the role of strategic interdependencies and spillovers, including free-riding in R&D financing, learning-by-doing effects, drug shortages, reference pricing, and parallel trade. We then provide new evidence on the international spillovers of pull incentives on innovation, showing that international cooperation and innovative institutions are necessary to better align national regulations with the global objective of sustaining pharmaceutical innovation.
Item Type: | Monograph (Working Paper) |
---|---|
Language: | English |
Date: | October 2025 |
Place of Publication: | Toulouse |
Uncontrolled Keywords: | Pharmaceutical Regulation, Innovation, R&D, International Spillovers |
JEL Classification: | I10 - General I11 - Analysis of Health Care Markets I18 - Government Policy; Regulation; Public Health L10 - General L20 - General |
Subjects: | B- ECONOMIE ET FINANCE |
Divisions: | TSE-R (Toulouse) |
Institution: | Université Toulouse Capitole |
Site: | UT1 |
Date Deposited: | 13 Oct 2025 06:11 |
Last Modified: | 13 Oct 2025 06:39 |
OAI Identifier: | oai:tse-fr.eu:131002 |
URI: | https://publications.ut-capitole.fr/id/eprint/51274 |